For the first time in over 25 years (since the approval of oxybutynin in 1972), better medications are available for the overactive bladder. With the recent approval of tolterodine and oxybutynin ...

The mechanism by which sacral nerve stimulation influences a dysfunctional bladder is not fully understood ... as both a surgeon and prescriber of medication must apply to OAB therapy.

Are you having problems with your bladder? There may be a more profound cause for the suffering than a random nuisance. The ...

1 There are several treatment options for patients with overactive bladder or neurogenic detrusor overactivity, including behavioral treatment, drugs, catheterization, physiotherapy, and surgery.

Overactive bladder is a well established and bothersome clinical condition for which antimuscarinic drugs are the treatment of choice. Oxybutynin, the longest established antimuscarinic, is a ...

Botox is a prescription drug that’s used to treat certain bladder problems, such as overactive bladder (OAB) in adults. For certain bladder problems, Botox may also be prescribed to children ...

Frequent urination often signals underlying health conditions that require medical attention. While occasional increases in ...

Prescription medications can ease overactive bladder symptoms. Supplements for overactive bladder may help, although little robust evidence supports their value. An overactive bladder (OAB ...

When this happens, symptoms associated with overactive bladder are reduced. Medications that fall under the beta-3 adrenergic ...

Gemtesa (vibegron) is a prescription drug used to treat symptoms of overactive bladder (OAB). Gemtesa can cause side effects that range from mild to serious. Examples include headache, nausea ...

In new guidance published by the Health Service's regulatory body today, the medication was recommended for adults suffering ...

One in six adults have bladder control problems. It can disrupt sleep or cause accidents, lead to social isolation and depression and affects women more than men.